News tagged with cholesterol drug
Related topics: food and drug administration
More 'good' cholesterol is not always good for your health
(PhysOrg.com) -- We've all heard about the importance of raising HDL, or the so-called "good" cholesterol, and lowering LDL, or "bad" cholesterol, to improve heart health. While we've come to assume HDL cholesterol ...
May 25, 2010 |
5 / 5 (5) |
3
|
Possible new route to fight dengue virus pointed
Researchers have identified enzymes and biochemical compounds called lipids that are targeted and modified by the dengue virus during infection, suggesting a potential new approach to control the aggressive ...
Mar 22, 2012 |
5 / 5 (3) |
0
|
Researchers identify structure of apolipoprotein
Using a sophisticated technique of x-ray crystallography, researchers Xiaohu Mei, PhD, and David Atkinson, PhD, from Boston University School of Medicine (BUSM) have for the first time obtained an "image" of the structure ...
Nov 04, 2011 |
not rated yet |
0
|
'Fatostatin' is a turnoff for fat genes
A small molecule earlier found to have both anti-fat and anti-cancer abilities works as a literal turnoff for fat-making genes, according to a new report in the August 28th issue of the journal Chemistry and Biology, a Cell ...
Aug 27, 2009 |
2.5 / 5 (2) |
2
Capsules Encapsulated: Enzyme-equipped liposomes embedded in polymer capsules as a novel biomedical transport system
(PhysOrg.com) -- When cells cannot carry out the tasks required of them by our bodies, the result is disease. Nanobiotechnology researchers are looking for ways to allow synthetic systems take over simple cellular activities ...
May 19, 2009 |
5 / 5 (1) |
0
X-rays help advance the battle against heart disease
(PhysOrg.com) -- Scientists from Imperial College London and Diamond Light Source have revealed the structure of a cholesterol-lowering-drug target. Published in the journal Nature, this finding could lead ...
Oct 06, 2011 |
not rated yet |
0
Drugmakers brace for generic versions of biotech blockbusters
In 2001, Abbott Laboratories spent nearly $7 billion on the biggest acquisition in the company's 123-year history, primarily to access one drug, Humira.
Medicine & Health / Medications
May 27, 2011 |
5 / 5 (1) |
0
Drug reduces gum disease, risk of osteoporosis, heart disease in women
(PhysOrg.com) -- New research has shown that a federally approved pharmaceutical for treating periodontal disease also significantly reduces risk of osteoporosis and cardiovascular disease in postmenopausal ...
Medicine & Health / Medications
Mar 10, 2011 |
5 / 5 (2) |
0
NIH stops study of niacin to prevent heart attacks
(AP) -- Disappointing news: A drug that raises people's so-called good cholesterol didn't go on to prevent heart attacks.
Medicine & Health / Medications
May 26, 2011 |
not rated yet |
0
Toward new medications for chronic brain diseases
A needle-in-the-haystack search through nearly 390,000 chemical compounds had led scientists to a substance that can sneak through the protective barrier surrounding the brain with effects promising for new drugs for Parkinson's ...
Apr 20, 2011 |
5 / 5 (1) |
0
New protein could prove powerful target for cholesterol lowering drugs
A protein has been discovered that may have a profound effect on cholesterol metabolism. That discovery raises the possibility that the protein, dubbed IDOL, could be a powerful target for cholesterol-lowering drugs, says ...
May 17, 2011 |
not rated yet |
0
Active ingredient levels vary among red yeast rice supplements
Different formulations of red yeast rice, a supplement marketed as a way to improve cholesterol levels, appear widely inconsistent in the amounts of active ingredients they contain, according to a report in the October 25 ...
Medicine & Health / Medications
Oct 25, 2010 |
5 / 5 (2) |
1
US Supreme Court allows cholesterol drug suit
The US Supreme Court on Thursday allowed a class-action suit by alleged victims of the anti-cholesterol drug Baycol, which was taken off the market in 2001 by German pharmaceuticals giant Bayer.
Medicine & Health / Medications
Jun 16, 2011 |
not rated yet |
0
Cholesterol drug may have role in treating prostate cancer
A drug commonly prescribed for people with high cholesterol may also be effective in treating prostate cancer, according to new research by Dr. Xiao-Yan Wen at St. Michael's Hospital.
Sep 20, 2010 |
4 / 5 (1) |
1
Pfizer will buy King Pharmaceuticals for $3.6B
(AP) -- Pfizer Inc. said Tuesday it will buy a company specializing in pain drugs in a $3.6 billion deal meant to shore up the portfolio of the world's largest drug company.
Oct 12, 2010 |
not rated yet |
0
